Gainers
- Avinger AVGR stock increased by 169.3% to $1.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.5 million.
- Carmell CTCX stock moved upwards by 85.32% to $0.42. The company's market cap stands at $8.7 million.
- Tivic Health Systems TIVC stock rose 69.47% to $0.38. The market value of their outstanding shares is at $3.1 million.
- NeueHealth NEUE shares rose 63.57% to $7.05. The market value of their outstanding shares is at $58.4 million.
- 180 Life Sciences ATNF shares rose 39.03% to $2.6. The company's market cap stands at $5.1 million.
- Theriva Biologics TOVX shares increased by 23.07% to $1.6. The market value of their outstanding shares is at $4.4 million.
Losers
- KalVista Pharma KALV stock fell 20.7% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $345.9 million.
- Anebulo Pharmaceuticals ANEB shares declined by 16.0% to $1.05. The market value of their outstanding shares is at $27.2 million.
- Dogwood Therapeutics DWTX stock declined by 13.61% to $2.35. The company's market cap stands at $3.1 million.
- Traws Pharma TRAW stock fell 12.1% to $11.05. The market value of their outstanding shares is at $33.4 million.
- Astria Therapeutics ATXS stock fell 11.77% to $8.4. The market value of their outstanding shares is at $474.0 million.
- Ocean Biomedical OCEA stock fell 11.74% to $0.56. The company's market cap stands at $19.6 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ATNF180 Life Sciences Corp
$1.46-5.19%
ATXSAstria Therapeutics Inc
$7.51-0.40%
AVGRAvinger Inc
$0.5325-6.82%
CTCXCarmell Corp
$0.4301-1.80%
DWTXDogwood Therapeutics Inc
$15.13-13.1%
KALVKalVista Pharmaceuticals Inc
$8.871.14%
NEUENeueHealth Inc
$7.31-0.27%
OCEAOcean Biomedical Inc
$0.35994.93%
TIVCTivic Health Systems Inc
$0.2386-8.12%
TOVXTheriva Biologics Inc
$1.29-3.73%
TRAWTraws Pharma Inc
$7.120.99%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in